Nanalysis Scientific Corp. (TSXV: NSCI)

Market Cap	35.06M
Revenue (ttm)	43.01M
Net Income (ttm)	-8.28M
Shares Out	113.10M
EPS (ttm)	-0.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,910
Open	0.310
Previous Close	0.295
Day's Range	0.310 - 0.310
52-Week Range	0.250 - 0.600
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 30, 2025

About Nanalysis Scientific

Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Canada, Europe, Asia, and internationally. The company operates through Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; 60 MHz and 100 MHz NMR platform; and Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides and software products, such as NMRGui...

• Industry: Scientific & Technical Instruments
• Sector: Technology
• CEO: Sean Krakiwsky
• Employees: 249
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NSCI

Financial Performance

In 2023, Nanalysis Scientific's revenue was 28.47 million, an increase of 14.69% compared to the previous year's 24.82 million. Losses were -16.20 million, 78.0% more than in 2022.